Name | Number of supported studies | Average coverage | |
---|---|---|---|
classical monocyte | 14 studies | 25% ± 8% | |
ciliated cell | 13 studies | 34% ± 14% | |
macrophage | 9 studies | 22% ± 7% | |
non-classical monocyte | 9 studies | 25% ± 8% | |
CD8-positive, alpha-beta T cell | 7 studies | 17% ± 2% | |
monocyte | 6 studies | 18% ± 3% | |
epithelial cell | 6 studies | 31% ± 11% | |
conventional dendritic cell | 5 studies | 27% ± 9% | |
natural killer cell | 5 studies | 18% ± 3% | |
regulatory T cell | 5 studies | 18% ± 3% | |
smooth muscle cell | 4 studies | 18% ± 3% | |
enterocyte | 4 studies | 19% ± 1% | |
fibroblast | 4 studies | 27% ± 13% | |
endothelial cell | 4 studies | 21% ± 5% | |
oligodendrocyte | 3 studies | 23% ± 6% | |
pericyte | 3 studies | 22% ± 2% | |
myeloid cell | 3 studies | 27% ± 7% | |
exhausted T cell | 3 studies | 19% ± 2% | |
intermediate monocyte | 3 studies | 30% ± 9% | |
dendritic cell | 3 studies | 30% ± 9% | |
basal cell | 3 studies | 32% ± 13% | |
connective tissue cell | 3 studies | 27% ± 9% | |
plasmacytoid dendritic cell | 3 studies | 18% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 1268.77 | 2639 / 2642 | 100% | 49.60 | 705 / 705 |
thymus | 100% | 1589.84 | 653 / 653 | 100% | 54.29 | 604 / 605 |
uterus | 100% | 1257.79 | 170 / 170 | 100% | 63.57 | 457 / 459 |
liver | 100% | 891.39 | 226 / 226 | 100% | 46.91 | 404 / 406 |
esophagus | 100% | 1440.24 | 1445 / 1445 | 99% | 35.32 | 182 / 183 |
adrenal gland | 100% | 1128.61 | 258 / 258 | 99% | 59.81 | 228 / 230 |
prostate | 100% | 1208.65 | 245 / 245 | 99% | 40.55 | 497 / 502 |
intestine | 100% | 1225.97 | 965 / 966 | 99% | 51.14 | 520 / 527 |
kidney | 100% | 1176.85 | 89 / 89 | 99% | 38.21 | 888 / 901 |
skin | 100% | 1396.74 | 1809 / 1809 | 99% | 73.90 | 465 / 472 |
bladder | 100% | 1326.52 | 21 / 21 | 98% | 72.03 | 495 / 504 |
ovary | 100% | 1009.26 | 180 / 180 | 98% | 34.02 | 422 / 430 |
stomach | 100% | 1036.04 | 359 / 359 | 98% | 45.21 | 280 / 286 |
lung | 99% | 1055.11 | 575 / 578 | 98% | 43.53 | 1130 / 1155 |
breast | 100% | 1201.22 | 459 / 459 | 96% | 43.58 | 1078 / 1118 |
pancreas | 97% | 536.53 | 319 / 328 | 99% | 60.77 | 176 / 178 |
adipose | 100% | 1273.64 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 75.32 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 73.59 | 29 / 29 |
spleen | 100% | 1136.63 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 58.50 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 25.99 | 1 / 1 |
heart | 100% | 978.40 | 857 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1195.76 | 1328 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1019.90 | 796 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 791.15 | 904 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006508 | Biological process | proteolysis |
GO_0016579 | Biological process | protein deubiquitination |
GO_0005829 | Cellular component | cytosol |
GO_0005515 | Molecular function | protein binding |
GO_0004843 | Molecular function | cysteine-type deubiquitinase activity |
Gene name | JOSD2 |
Protein name | ubiquitinyl hydrolase 1 (EC 3.4.19.12) Josephin-2 (EC 3.4.19.12) (Josephin domain-containing protein 2) |
Synonyms | SBBI54 |
Description | FUNCTION: Cleaves 'Lys-63'-linked poly-ubiquitin chains, and with lesser efficiency 'Lys-48'-linked poly-ubiquitin chains (in vitro). May act as a deubiquitinating enzyme. . |
Accessions | M0QZL8 ENST00000598418.6 [Q8TAC2-1] ENST00000595669.5 [Q8TAC2-2] ENST00000594350.1 Q7Z7N5 ENST00000601423.5 [Q8TAC2-1] Q8TAC2 |